Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR

Lancet Respir Med 2014 Jul doi: 10.1016/S2213-2600(14)70101-8

English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis.

Barton JL, Trupin L, Tonner C, Imboden J, Katz P, Schillinger D, Yelin E

J Rheumatol 2014 Jul doi: 10.3899/jrheum.131350

Ecological dynamics and biotechnological implications of thraustochytrids from marine habitats.

Singh P, Liu Y, Li L, Wang G

Appl Microbiol Biotechnol 2014 Jul doi: 10.1007/s00253-014-5780-x

The disability burden associated with stroke emerges before stroke onset and differentially affects blacks: results from the health and retirement study cohort.

Capistrant BD, Mejia NI, Liu SY, Wang Q, Glymour MM

J Gerontol A Biol Sci Med Sci 2014 Jul doi: 10.1093/gerona/glt191

Assessment of the smoke-free outdoor regulation in the WHO European Region.

Martínez C, Guydish J, Robinson G, Martínez-Sánchez JM, Fernández E

Prev Med 2014 Jul doi: 10.1016/j.ypmed.2014.03.020

Cylus et al. respond to "unrealized benefits?".

Cylus J, Glymour MM, Avendano M

Am J Epidemiol 2014 Jul doi: 10.1093/aje/kwu105

No evidence found that hospitals are using new electronic health records to increase Medicare reimbursements.

By: Adler-Milstein J, Jha AK

Health Aff (Millwood) 2014 Jul doi: 10.1377/hlthaff.2014.0023

Infectious complication of Blunt head injury.

Kanzaria HK, Detz A

Emerg Med J 2014 Jul doi: 10.1136/emermed-2013-203158

Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.

Roan NR, Liu H, Usmani SM, Neidleman J, Müller JA, Avila-Herrera A, Gawanbacht A, Zirafi O, Chu S, Dong M, Kumar ST, Smith JF, Pollard KS, Fändrich M, Kirchhoff F, Münch J, Witkowska HE, Greene WC

J Virol 2014 Jul doi: 10.1128/JVI.00269-14

Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.

Richeldi L, Cottin V, Flaherty KR, Kolb M, Inoue Y, Raghu G, Taniguchi H, Hansell DM, Nicholson AG, Le Maulf F, Stowasser S, Collard HR

Respir Med 2014 Jul doi: 10.1016/j.rmed.2014.04.011